Cite
HARVARD Citation
Hatch, S. et al. (n.d.). XPF protein levels determine sensitivity of malignant melanoma cells to oxaliplatin chemotherapy: Suitability as a biomarker for patient selection. International journal of cancer. 134 (6), pp. 1495-1503. [Online].